Quick Answer
GUIDED THERAPEUTICS INC reported Operating Income Loss of -$2.37 million for the year ending 2025.
- GUIDED THERAPEUTICS INC showed a decrease of -12.5% in Operating Income Loss from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Operating Income Loss has declined by 46.3%.
- Historical annual values: Fiscal year 2025: -$2.37 million | Fiscal year 2024: -$2.11 million | Fiscal year 2023: -$3.46 million | Fiscal year 2022: -$3.33 million | Fiscal year 2021: -$2.36 million | Fiscal year 2020: -$1.05 million | Fiscal year 2019: -$937.0 thousand | Fiscal year 2018: -$1.55 million | Fiscal year 2017: -$3.12 million | Fiscal year 2016: -$3.82 million | Fiscal year 2015: -$6.23 million | Fiscal year 2014: -$8.67 million | Fiscal year 2013: -$6.61 million | Fiscal year 2012: -$4.28 million | Fiscal year 2011: -$6.76 million | Fiscal year 2010: -$1.62 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: